{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:54:29Z","timestamp":1782345269383,"version":"3.54.5"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10555-020-09949-9","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T03:03:18Z","timestamp":1609729398000},"page":"341-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and\/or immunotherapy) in brain metastases: a systematic review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-4338","authenticated-orcid":false,"given":"Pierre-Yves","family":"Borius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"R\u00e9gis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kalamarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Ambroise","family":"Valery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Latorzeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"9949_CR1","doi-asserted-by":"publisher","unstructured":"Yamamoto, M., Higuchi, Y., Sato, Y., Aiyama, H., Kasuya, H., & Barfod, B. E. (2019). Stereotactic radiosurgery for patients with 10 or more brain metastases. In A. Niranjan, L. D. Lunsford, & H. Kano (Eds.), Progress in neurological surgery (Vol. 34, pp. 110\u2013124). S. Karger AG. https:\/\/doi.org\/10.1159\/000493056.","DOI":"10.1159\/000493056"},{"issue":"12","key":"9949_CR2","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1093\/annonc\/mdx408","volume":"28","author":"AV Tallet","year":"2017","unstructured":"Tallet, A. V., Dhermain, F., Le Rhun, E., No\u00ebl, G., & Kirova, Y. M. (2017). Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Annals of Oncology, 28(12), 2962\u20132976. https:\/\/doi.org\/10.1093\/annonc\/mdx408.","journal-title":"Annals of Oncology"},{"issue":"2","key":"9949_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ijrobp.2016.01.038","volume":"95","author":"CJ Anker","year":"2016","unstructured":"Anker, C. J., Grossmann, K. F., Atkins, M. B., Suneja, G., Tarhini, A. A., & Kirkwood, J. M. (2016). Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: consensus guidelines from the Eastern Cooperative Oncology Group (ECOG). International Journal of Radiation Oncology, Biology, Physics, 95(2), 632\u2013646. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.01.038.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"9949_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1634\/theoncologist.2016-0117","volume":"22","author":"M Verduin","year":"2017","unstructured":"Verduin, M., Zindler, J. D., Martinussen, H. M. A., Jansen, R. L. H., Croes, S., Hendriks, L. E. L., Eekers, D. B. P., & Hoeben, A. (2017). Use of systemic therapy concurrent with cranial radiotherapy for cerebral metastases of solid tumors. Oncologist, 22(2), 222\u2013235. https:\/\/doi.org\/10.1634\/theoncologist.2016-0117.","journal-title":"Oncologist"},{"key":"9949_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2018.01.067","volume":"93","author":"A Levy","year":"2018","unstructured":"Levy, A., Faivre-Finn, C., Hasan, B., De Maio, E., Berghoff, A. S., Girard, N., et al. (2018). Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. European Journal of Cancer, 93, 37\u201346. https:\/\/doi.org\/10.1016\/j.ejca.2018.01.067.","journal-title":"European Journal of Cancer"},{"issue":"1","key":"9949_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2407-7-18","volume":"7","author":"R Addeo","year":"2007","unstructured":"Addeo, R., Caraglia, M., Faiola, V., Capasso, E., Vincenzi, B., Montella, L., et al. (2007). Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer, 7(1), 18. https:\/\/doi.org\/10.1186\/1471-2407-7-18.","journal-title":"BMC Cancer"},{"issue":"1","key":"9949_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/annonc\/mdu488","volume":"26","author":"KI Cao","year":"2015","unstructured":"Cao, K. I., Lebas, N., Gerber, S., Levy, C., Le Scodan, R., Bourgier, C., et al. (2015). Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer. Annals of Oncology, 26(1), 89\u201394. https:\/\/doi.org\/10.1093\/annonc\/mdu488.","journal-title":"Annals of Oncology"},{"issue":"3","key":"9949_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.radonc.2018.01.005","volume":"126","author":"DN Cagney","year":"2018","unstructured":"Cagney, D. N., Martin, A. M., Catalano, P. J., Reitman, Z. J., Mezochow, G. A., Lee, E. Q., Wen, P. Y., Weiss, S. E., Brown, P. D., Ahluwalia, M. S., Arvold, N. D., Tanguturi, S. K., Haas-Kogan, D. A., Alexander, B. M., Redig, A. J., & Aizer, A. A. (2018). Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation. Radiotherapy and Oncology, 126(3), 511\u2013518. https:\/\/doi.org\/10.1016\/j.radonc.2018.01.005.","journal-title":"Radiotherapy and Oncology"},{"key":"9949_CR9","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/j.wneu.2019.03.193","volume":"127","author":"S-AL Morris","year":"2019","unstructured":"Morris, S.-A. L., Zhu, P., Rao, M., Martir, M., Zhu, J. J., Hsu, S., Ballester, L. Y., Day, A. L., Tandon, N., Kim, D. H., Shepard, S., Blanco, A., & Esquenazi, Y. (2019). Gamma knife stereotactic radiosurgery in combination with bevacizumab for recurrent glioblastoma. World Neurosurgery, 127, e523\u2013e533. https:\/\/doi.org\/10.1016\/j.wneu.2019.03.193.","journal-title":"World Neurosurgery"},{"issue":"5","key":"9949_CR10","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ijrobp.2010.12.074","volume":"82","author":"KC Cuneo","year":"2012","unstructured":"Cuneo, K. C., Vredenburgh, J. J., Sampson, J. H., Reardon, D. A., Desjardins, A., Peters, K. B., Friedman, H. S., Willett, C. G., & Kirkpatrick, J. P. (2012). Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. International Journal of Radiation Oncology, Biology, Physics, 82(5), 2018\u20132024. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.12.074.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"9949_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11060-014-1488-0","volume":"119","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Wang, E., Pan, L., Dai, J., Zhang, N., Wang, X., Liu, X., Mei, G., & Sheng, X. (2014). A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema. Journal of Neuro-Oncology, 119(2), 369\u2013376. https:\/\/doi.org\/10.1007\/s11060-014-1488-0.","journal-title":"Journal of Neuro-Oncology"},{"issue":"1","key":"9949_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11060-015-2019-3","volume":"127","author":"S Yomo","year":"2016","unstructured":"Yomo, S., & Hayashi, M. (2016). Salvage stereotactic radiosurgery with adjuvant use of bevacizumab for heavily treated recurrent brain metastases: a preliminary report. Journal of Neuro-Oncology, 127(1), 119\u2013126. https:\/\/doi.org\/10.1007\/s11060-015-2019-3.","journal-title":"Journal of Neuro-Oncology"},{"key":"9949_CR13","doi-asserted-by":"publisher","first-page":"1047.e1","DOI":"10.1016\/j.wneu.2017.07.185","volume":"107","author":"J Guinde","year":"2017","unstructured":"Guinde, J., Carron, R., Tomasini, P., Greillier, L., R\u00e9gis, J., & Barlesi, F. (2017). Bevacizumab plus radiosurgery for nonsquamous non\u2013small cell lung cancer patients with brain metastases: safe combination? World Neurosurgery, 107, 1047.e1\u20131047.e4. https:\/\/doi.org\/10.1016\/j.wneu.2017.07.185.","journal-title":"World Neurosurgery"},{"key":"9949_CR14","doi-asserted-by":"publisher","unstructured":"Staehler, M., Haseke, N., Nuhn, P., T\u00fcllmann, C., Karl, A., Siebels, M., Stief, C. G., Wowra, B., & Muacevic, A. (2011). Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma: anti-angiogenic therapy and radiosurgery in metastatic RCC. BJU International, no-no. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09895.x.","DOI":"10.1111\/j.1464-410X.2010.09895.x"},{"issue":"1","key":"9949_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3171\/2018.8.JNS182100","volume":"132","author":"A Juloori","year":"2020","unstructured":"Juloori, A., Miller, J. A., Parsai, S., Kotecha, R., Ahluwalia, M. S., Mohammadi, A. M., Murphy, E. S., Suh, J. H., Barnett, G. H., Yu, J. S., Vogelbaum, M. A., Rini, B., Garcia, J., Stevens, G. H., Angelov, L., & Chao, S. T. (2020). Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases. Journal of Neurosurgery, 132(1), 188\u2013196. https:\/\/doi.org\/10.3171\/2018.8.JNS182100.","journal-title":"Journal of Neurosurgery"},{"issue":"3","key":"9949_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11060-015-1862-6","volume":"124","author":"MS Ahluwalia","year":"2015","unstructured":"Ahluwalia, M. S., Chao, S. T., Parsons, M. W., Suh, J. H., Wang, D., Mikkelsen, T., Brewer, C. J., Smolenski, K. N., Schilero, C., Rump, M., Elson, P., Angelov, L., Barnett, G. H., Vogelbaum, M. A., Weil, R. J., & Peereboom, D. M. (2015). Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1\u20133 newly diagnosed brain metastases. Journal of Neuro-Oncology, 124(3), 485\u2013491. https:\/\/doi.org\/10.1007\/s11060-015-1862-6.","journal-title":"Journal of Neuro-Oncology"},{"issue":"2","key":"9949_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11060-017-2455-3","volume":"133","author":"K Arneson","year":"2017","unstructured":"Arneson, K., Mondschein, J., Stavas, M., Cmelak, A. J., Attia, A., Horn, L., Niermann, K., Puzanov, I., Chakravarthy, A. B., & Xia, F. (2017). A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases. Journal of Neuro-Oncology, 133(2), 435\u2013442. https:\/\/doi.org\/10.1007\/s11060-017-2455-3.","journal-title":"Journal of Neuro-Oncology"},{"issue":"4","key":"9949_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ijrobp.2007.07.2382","volume":"70","author":"AL Schwer","year":"2008","unstructured":"Schwer, A. L., Damek, D. M., Kavanagh, B. D., Gaspar, L. E., Lillehei, K., Stuhr, K., & Chen, C. (2008). A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. International Journal of Radiation Oncology, Biology, Physics, 70(4), 993\u20131001. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.07.2382.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"9949_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3340\/jkns.2015.58.3.205","volume":"58","author":"HJ Kim","year":"2015","unstructured":"Kim, H. J., Kim, W. S., Kwon, D. H., Cho, Y. H., & Choi, C.-M. (2015). Effects of an epithelial growth factor receptor-tyrosine kinase inhibitor add-on in stereotactic radiosurgery for brain metastases originating from non-small-cell lung Cancer. Journal of Korean Neurosurgical Society, 58(3), 205. https:\/\/doi.org\/10.3340\/jkns.2015.58.3.205.","journal-title":"Journal of Korean Neurosurgical Society"},{"issue":"5","key":"9949_CR20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.ijrobp.2012.11.042","volume":"85","author":"PW Sperduto","year":"2013","unstructured":"Sperduto, P. W., Wang, M., Robins, H. I., Schell, M. C., Werner-Wasik, M., Komaki, R., Souhami, L., Buyyounouski, M. K., Khuntia, D., Demas, W., Shah, S. A., Nedzi, L. A., Perry, G., Suh, J. H., & Mehta, M. P. (2013). A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. International Journal of Radiation Oncology, Biology, Physics, 85(5), 1312\u20131318. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.11.042.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"9949_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-019-03282-0","volume":"145","author":"S Yomo","year":"2019","unstructured":"Yomo, S., Serizawa, T., Yamamoto, M., Higuchi, Y., Sato, Y., Shuto, T., Akabane, A., Jokura, H., Kawagishi, J., & Aoyama, H. (2019). The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after gamma knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI). Journal of Neuro-Oncology, 145(1), 151\u2013157. https:\/\/doi.org\/10.1007\/s11060-019-03282-0.","journal-title":"Journal of Neuro-Oncology"},{"key":"9949_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fonc.2020.00012","volume":"10","author":"H Zhuang","year":"2020","unstructured":"Zhuang, H., Tao, L., Wang, X., Shi, S., Yuan, Z., Wang, E., & Chang, J. Y. (2020). Tyrosine kinase inhibitor resistance increased the risk of cerebral radiation necrosis after stereotactic radiosurgery in brain metastases of non-small-cell lung cancer: a multi-institutional retrospective case-control study. Frontiers in Oncology, 10, 12. https:\/\/doi.org\/10.3389\/fonc.2020.00012.","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"9949_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11060-013-1046-1","volume":"112","author":"S Yomo","year":"2013","unstructured":"Yomo, S., Hayashi, M., & Cho, N. (2013). Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer. Journal of Neuro-Oncology, 112(2), 199\u2013207. https:\/\/doi.org\/10.1007\/s11060-013-1046-1.","journal-title":"Journal of Neuro-Oncology"},{"issue":"5","key":"9949_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/neuonc\/noz006","volume":"21","author":"JM Kim","year":"2019","unstructured":"Kim, J. M., Miller, J. A., Kotecha, R., Chao, S. T., Ahluwalia, M. S., Peereboom, D. M., Mohammadi, A. M., Barnett, G. H., Murphy, E. S., Vogelbaum, M. A., Angelov, L., Abraham, J., Moore, H., Budd, G. T., & Suh, J. H. (2019). Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis. Neuro-Oncology, 21(5), 659\u2013668. https:\/\/doi.org\/10.1093\/neuonc\/noz006.","journal-title":"Neuro-Oncology"},{"issue":"2","key":"9949_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3171\/2018.10.JNS182340","volume":"132","author":"S Parsai","year":"2020","unstructured":"Parsai, S., Miller, J. A., Juloori, A., Chao, S. T., Kotecha, R., Mohammadi, A. M., Ahluwalia, M. S., Murphy, E. S., Barnett, G. H., Vogelbaum, M. A., Angelov, L., Peereboom, D. M., & Suh, J. H. (2020). Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases. Journal of Neurosurgery, 132(2), 503\u2013511. https:\/\/doi.org\/10.3171\/2018.10.JNS182340.","journal-title":"Journal of Neurosurgery"},{"issue":"1","key":"9949_CR26","doi-asserted-by":"publisher","first-page":"45193","DOI":"10.1038\/srep45193","volume":"7","author":"Y Fan","year":"2017","unstructured":"Fan, Y., Xu, Y., Gong, L., Fang, L., Lu, H., Qin, J., et al. (2017). Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases. Scientific Reports, 7(1), 45193. https:\/\/doi.org\/10.1038\/srep45193.","journal-title":"Scientific Reports"},{"issue":"6","key":"9949_CR27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1634\/theoncologist.2018-0264","volume":"24","author":"L Xie","year":"2019","unstructured":"Xie, L., Nagpal, S., Wakelee, H. A., Li, G., Soltys, S. G., & Neal, J. W. (2019). Osimertinib for EGFR -mutant lung cancer with brain metastases: results from a single-center retrospective study. Oncologist, 24(6), 836\u2013843. https:\/\/doi.org\/10.1634\/theoncologist.2018-0264.","journal-title":"Oncologist"},{"key":"9949_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fonc.2019.00377","volume":"9","author":"K Armstrong","year":"2019","unstructured":"Armstrong, K., Ward, J., Dunne, M., Rock, L., Westrup, J., Mascott, C. R., Thirion, P., & Mihai, A. M. (2019). Linac-based radiosurgery for patients with brain oligometastases from a breast primary, in the trastuzumab era-impact of tumor phenotype and prescribed SRS dose. Frontiers in Oncology, 9, 377. https:\/\/doi.org\/10.3389\/fonc.2019.00377.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"9949_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11060-016-2265-z","volume":"131","author":"A Geraud","year":"2017","unstructured":"Geraud, A., Xu, H. P., Beuzeboc, P., & Kirova, Y. M. (2017). Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer. Journal of Neuro-Oncology, 131(1), 69\u201372. https:\/\/doi.org\/10.1007\/s11060-016-2265-z.","journal-title":"Journal of Neuro-Oncology"},{"issue":"13","key":"9949_CR30","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1158\/1078-0432.CCR-18-2851","volume":"25","author":"PK Stumpf","year":"2019","unstructured":"Stumpf, P. K., Cittelly, D. M., Robin, T. P., Carlson, J. A., Stuhr, K. A., Contreras-Zarate, M. J., Lai, S., Ormond, D. R., Rusthoven, C. G., Gaspar, L. E., Rabinovitch, R., Kavanagh, B. D., Liu, A., Diamond, J. R., Kabos, P., & Fisher, C. M. (2019). Combination of trastuzumab emtansine and stereotactic radiosurgery results in high rates of clinically significant radionecrosis and dysregulation of aquaporin-4. Clinical Cancer Research, 25(13), 3946\u20133953. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2851.","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"9949_CR31","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/annonc\/mdv139","volume":"26","author":"M Hecht","year":"2015","unstructured":"Hecht, M., Zimmer, L., Loquai, C., Weishaupt, C., Gutzmer, R., Schuster, B., Gleisner, S., Schulze, B., Goldinger, S. M., Berking, C., Forschner, A., Clemens, P., Grabenbauer, G., M\u00fcller-Brenne, T., Bauch, J., Eich, H. T., Grabbe, S., Schadendorf, D., Schuler, G., Keikavoussi, P., Semrau, S., Fietkau, R., Distel, L. V., & Heinzerling, L. (2015). Radiosensitization by BRAF inhibitor therapy\u2014mechanism and frequency of toxicity in melanoma patients. Annals of Oncology, 26(6), 1238\u20131244. https:\/\/doi.org\/10.1093\/annonc\/mdv139.","journal-title":"Annals of Oncology"},{"issue":"30","key":"9949_CR32","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1200\/JCO.2013.50.8473","volume":"31","author":"N Rompoti","year":"2013","unstructured":"Rompoti, N., Schilling, B., Livingstone, E., Griewank, K., Hillen, U., Sauerwein, W., P\u00f6ttgen, C., Stuschke, M., Schadendorf, D., & Zimmer, L. (2013). Combination of BRAF inhibitors and brain radiotherapy in patients with metastatic melanoma shows minimal acute toxicity. Journal of Clinical Oncology, 31(30), 3844\u20133845. https:\/\/doi.org\/10.1200\/JCO.2013.50.8473.","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"9949_CR33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1684\/ejd.2013.2193","volume":"23","author":"L Peuvrel","year":"2013","unstructured":"Peuvrel, L., Ruellan, A.-L., Thillays, F., Quereux, G., Brocard, A., Saint-Jean, M., Aumont, M., Drouet, F., & Dreno, B. (2013). Severe radiotherapy-induced extracutaneous toxicity under vemurafenib. European Journal of Dermatology, 23(6), 879\u2013881. https:\/\/doi.org\/10.1684\/ejd.2013.2193.","journal-title":"European Journal of Dermatology"},{"issue":"10","key":"9949_CR34","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdu266","volume":"25","author":"C Gaudy-Marqueste","year":"2014","unstructured":"Gaudy-Marqueste, C., Carron, R., Delsanti, C., Loundou, A., Monestier, S., Archier, E., Richard, M. A., Regis, J., & Grob, J. J. (2014). On demand gamma-knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases. Annals of Oncology, 25(10), 2086\u20132091. https:\/\/doi.org\/10.1093\/annonc\/mdu266.","journal-title":"Annals of Oncology"},{"issue":"3","key":"9949_CR35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3171\/2016.2.JNS1633","volume":"126","author":"Z Xu","year":"2017","unstructured":"Xu, Z., Lee, C.-C., Ramesh, A., Mueller, A. C., Schlesinger, D., Cohen-Inbar, O., Shih, H. H., & Sheehan, J. P. (2017). BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases. Journal of Neurosurgery, 126(3), 726\u2013734. https:\/\/doi.org\/10.3171\/2016.2.JNS1633.","journal-title":"Journal of Neurosurgery"},{"issue":"1","key":"9949_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-014-1685-x","volume":"122","author":"KA Ahmed","year":"2015","unstructured":"Ahmed, K. A., Freilich, J. M., Sloot, S., Figura, N., Gibney, G. T., Weber, J. S., Sarangkasiri, S., Chinnaiyan, P., Forsyth, P. A., Etame, A. B., & Rao, N. G. (2015). LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases. Journal of Neuro-Oncology, 122(1), 121\u2013126. https:\/\/doi.org\/10.1007\/s11060-014-1685-x.","journal-title":"Journal of Neuro-Oncology"},{"issue":"4","key":"9949_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.adro.2017.07.003","volume":"2","author":"S Acharya","year":"2017","unstructured":"Acharya, S., Mahmood, M., Mullen, D., Yang, D., Tsien, C. I., Huang, J., Perkins, S. M., Rich, K., Chicoine, M., Leuthardt, E., Dowling, J., Dunn, G., Keller, J., Robinson, C. G., & Abraham, C. (2017). Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents. Advances in Radiation Oncology, 2(4), 572\u2013580. https:\/\/doi.org\/10.1016\/j.adro.2017.07.003.","journal-title":"Advances in Radiation Oncology"},{"issue":"2","key":"9949_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3171\/2014.9.JNS141425","volume":"123","author":"D Ly","year":"2015","unstructured":"Ly, D., Bagshaw, H. P., Anker, C. J., Tward, J. D., Grossmann, K. F., Jensen, R. L., & Shrieve, D. C. (2015). Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. Journal of Neurosurgery, 123(2), 395\u2013401. https:\/\/doi.org\/10.3171\/2014.9.JNS141425.","journal-title":"Journal of Neurosurgery"},{"issue":"4","key":"9949_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/CMR.0000000000000268","volume":"26","author":"KR Patel","year":"2016","unstructured":"Patel, K. R., Chowdhary, M., Switchenko, J. M., Kudchadkar, R., Lawson, D. H., Cassidy, R. J., Prabhu, R. S., & Khan, M. K. (2016). BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis. Melanoma Research, 26(4), 387\u2013394. https:\/\/doi.org\/10.1097\/CMR.0000000000000268.","journal-title":"Melanoma Research"},{"issue":"4","key":"9949_CR40","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/neuros\/nyy203","volume":"84","author":"P Mastorakos","year":"2019","unstructured":"Mastorakos, P., Xu, Z., Yu, J., Hess, J., Qian, J., Chatrath, A., Taylor, D. G., Kondziolka, D., Warnick, R., Chiang, V., & Sheehan, J. (2019). BRAF V600 mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study. Neurosurgery, 84(4), 868\u2013880. https:\/\/doi.org\/10.1093\/neuros\/nyy203.","journal-title":"Neurosurgery"},{"issue":"3","key":"9949_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11060-016-2072-6","volume":"127","author":"A Wolf","year":"2016","unstructured":"Wolf, A., Zia, S., Verma, R., Pavlick, A., Wilson, M., Golfinos, J. G., Silverman, J. S., & Kondziolka, D. (2016). Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases. Journal of Neuro-Oncology, 127(3), 607\u2013615. https:\/\/doi.org\/10.1007\/s11060-016-2072-6.","journal-title":"Journal of Neuro-Oncology"},{"key":"9949_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.wneu.2016.08.046","volume":"95","author":"JW Choi","year":"2016","unstructured":"Choi, J. W., Kong, D.-S., Seol, H. J., Nam, D.-H., Yoo, K. H., Sun, J.-M., Ahn, J. S., Ahn, M. J., Park, K., & Lee, J.-I. (2016). Outcomes of gamma knife radiosurgery in combination with crizotinib for patients with brain metastasis from non\u2013small cell lung cancer. World Neurosurgery, 95, 399\u2013405. https:\/\/doi.org\/10.1016\/j.wneu.2016.08.046.","journal-title":"World Neurosurgery"},{"issue":"2","key":"9949_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1200\/JCO.2015.62.0138","volume":"34","author":"KL Johung","year":"2016","unstructured":"Johung, K. L., Yeh, N., Desai, N. B., Williams, T. M., Lautenschlaeger, T., Arvold, N. D., Ning, M. S., Attia, A., Lovly, C. M., Goldberg, S., Beal, K., Yu, J. B., Kavanagh, B. D., Chiang, V. L., Camidge, D. R., & Contessa, J. N. (2016). Extended survival and prognostic factors for patients with ALK -rearranged non\u2013small-cell lung cancer and brain metastasis. Journal of Clinical Oncology, 34(2), 123\u2013129. https:\/\/doi.org\/10.1200\/JCO.2015.62.0138.","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"9949_CR44","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11060-019-03260-6","volume":"144","author":"NB Figura","year":"2019","unstructured":"Figura, N. B., Potluri, T. K., Mohammadi, H., Oliver, D. E., Arrington, J. A., Robinson, T. J., Etame, A. B., Tran, N. D., Liu, J. K., Soliman, H., Forsyth, P. A., Sahebjam, S., Yu, H. M., Han, H. S., & Ahmed, K. A. (2019). CDK 4\/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases. Journal of Neuro-Oncology, 144(3), 583\u2013589. https:\/\/doi.org\/10.1007\/s11060-019-03260-6.","journal-title":"Journal of Neuro-Oncology"},{"issue":"4","key":"9949_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/CMR.0000000000000250","volume":"26","author":"BG Patel","year":"2016","unstructured":"Patel, B. G., Ahmed, K. A., Johnstone, P. A. S., Yu, H.-H. M., & Etame, A. B. (2016). Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases. Melanoma Research, 26(4), 382\u2013386. https:\/\/doi.org\/10.1097\/CMR.0000000000000250.","journal-title":"Melanoma Research"},{"key":"9949_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejca.2017.01.007","volume":"75","author":"ES Choong","year":"2017","unstructured":"Choong, E. S., Lo, S., Drummond, M., Fogarty, G. B., Menzies, A. M., Guminski, A., Shivalingam, B., Clarke, K., Long, G. V., & Hong, A. M. (2017). Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies. European Journal of Cancer, 75, 169\u2013178. https:\/\/doi.org\/10.1016\/j.ejca.2017.01.007.","journal-title":"European Journal of Cancer"},{"key":"9949_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.radonc.2018.08.025","volume":"130","author":"EJ Lehrer","year":"2019","unstructured":"Lehrer, E. J., Peterson, J., Brown, P. D., Sheehan, J. P., Qui\u00f1ones-Hinojosa, A., Zaorsky, N. G., & Trifiletti, D. M. (2019). Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: an international meta-analysis of individual patient data. Radiotherapy and Oncology, 130, 104\u2013112. https:\/\/doi.org\/10.1016\/j.radonc.2018.08.025.","journal-title":"Radiotherapy and Oncology"},{"issue":"5","key":"9949_CR48","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3171\/2016.9.JNS161585","volume":"127","author":"O Cohen-Inbar","year":"2017","unstructured":"Cohen-Inbar, O., Shih, H.-H., Xu, Z., Schlesinger, D., & Sheehan, J. P. (2017). The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab. Journal of Neurosurgery, 127(5), 1007\u20131014. https:\/\/doi.org\/10.3171\/2016.9.JNS161585.","journal-title":"Journal of Neurosurgery"},{"issue":"2","key":"9949_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-018-2880-y","volume":"139","author":"K Diao","year":"2018","unstructured":"Diao, K., Bian, S. X., Routman, D. M., Yu, C., Ye, J. C., Wagle, N. A., Wong, M. K., Zada, G., & Chang, E. L. (2018). Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity. Journal of Neuro-Oncology, 139(2), 421\u2013429. https:\/\/doi.org\/10.1007\/s11060-018-2880-y.","journal-title":"Journal of Neuro-Oncology"},{"issue":"2","key":"9949_CR50","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijrobp.2015.01.004","volume":"92","author":"AP Kiess","year":"2015","unstructured":"Kiess, A. P., Wolchok, J. D., Barker, C. A., Postow, M. A., Tabar, V., Huse, J. T., Chan, T. A., Yamada, Y., & Beal, K. (2015). Stereotactic radiosurgery for melanoma brain metastases in patients receiving Ipilimumab: safety profile and efficacy of combined treatment. International Journal of Radiation Oncology, Biology, Physics, 92(2), 368\u2013375. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.004.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"9949_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/CMR.0b013e32835f3d90","volume":"23","author":"M Mathew","year":"2013","unstructured":"Mathew, M., Tam, M., Ott, P. A., Pavlick, A. C., Rush, S. C., Donahue, B. R., Golfinos, J. G., Parker, E. C., Huang, P. P., & Narayana, A. (2013). Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Melanoma Research, 23(3), 191\u2013195. https:\/\/doi.org\/10.1097\/CMR.0b013e32835f3d90.","journal-title":"Melanoma Research"},{"issue":"3","key":"9949_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2217\/mmt-2016-0004","volume":"3","author":"AC Olson","year":"2016","unstructured":"Olson, A. C., Thomas, S., Qin, R., Singh, B., Salama, J. K., Kirkpatrick, J., & Salama, A. K. (2016). Outcomes and toxicity of stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab. Melanoma Management, 3(3), 177\u2013186. https:\/\/doi.org\/10.2217\/mmt-2016-0004.","journal-title":"Melanoma Management"},{"issue":"5","key":"9949_CR53","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/COC.0000000000000199","volume":"40","author":"KR Patel","year":"2017","unstructured":"Patel, K. R., Shoukat, S., Oliver, D. E., Chowdhary, M., Rizzo, M., Lawson, D. H., Khosa, F., Liu, Y., & Khan, M. K. (2017). Ipilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases. American Journal of Clinical Oncology, 40(5), 444\u2013450. https:\/\/doi.org\/10.1097\/COC.0000000000000199.","journal-title":"American Journal of Clinical Oncology"},{"issue":"3","key":"9949_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1283461","volume":"6","author":"T Skrepnik","year":"2017","unstructured":"Skrepnik, T., Sundararajan, S., Cui, H., & Stea, B. (2017). Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab. OncoImmunology, 6(3), e1283461. https:\/\/doi.org\/10.1080\/2162402X.2017.1283461.","journal-title":"OncoImmunology"},{"issue":"1","key":"9949_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cam4.315","volume":"4","author":"K Tazi","year":"2015","unstructured":"Tazi, K., Hathaway, A., Chiuzan, C., & Shirai, K. (2015). Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery. Cancer Medicine, 4(1), 1\u20136. https:\/\/doi.org\/10.1002\/cam4.315.","journal-title":"Cancer Medicine"},{"issue":"1","key":"9949_CR56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijrobp.2017.05.028","volume":"99","author":"NL Williams","year":"2017","unstructured":"Williams, N. L., Wuthrick, E. J., Kim, H., Palmer, J. D., Garg, S., Eldredge-Hindy, H., Daskalakis, C., Feeney, K. J., Mastrangelo, M. J., Kim, L. J., Sato, T., Kendra, K. L., Olencki, T., Liebner, D. A., Farrell, C. J., Evans, J. J., Judy, K. D., Andrews, D. W., Dicker, A. P., Werner-Wasik, M., & Shi, W. (2017). Phase 1 study of Ipilimumab combined with whole brain radiation therapy or radiosurgery for melanoma patients with brain metastases. International Journal of Radiation Oncology, Biology, Physics, 99(1), 22\u201330. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.028.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"9949_CR57","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/annonc\/mdv622","volume":"27","author":"KA Ahmed","year":"2016","unstructured":"Ahmed, K. A., Stallworth, D. G., Kim, Y., Johnstone, P. A. S., Harrison, L. B., Caudell, J. J., Yu, H. H. M., Etame, A. B., Weber, J. S., & Gibney, G. T. (2016). Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy. Annals of Oncology, 27(3), 434\u2013441. https:\/\/doi.org\/10.1093\/annonc\/mdv622.","journal-title":"Annals of Oncology"},{"issue":"1","key":"9949_CR58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40425-017-0282-x","volume":"5","author":"ES Anderson","year":"2017","unstructured":"Anderson, E. S., Postow, M. A., Wolchok, J. D., Young, R. J., Ballangrud, \u00c5., Chan, T. A., Yamada, Y., & Beal, K. (2017). Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment. Journal for Immunotherapy of Cancer, 5(1), 76. https:\/\/doi.org\/10.1186\/s40425-017-0282-x.","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"4","key":"9949_CR59","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jtho.2018.01.012","volume":"13","author":"HG Hubbeling","year":"2018","unstructured":"Hubbeling, H. G., Schapira, E. F., Horick, N. K., Goodwin, K. E. H., Lin, J. J., Oh, K. S., Shaw, A. T., Mehan, W. A., Shih, H. A., & Gainor, J. F. (2018). Safety of combined PD-1 pathway inhibition and intracranial radiation therapy in non\u2013small cell lung cancer. Journal of Thoracic Oncology, 13(4), 550\u2013558. https:\/\/doi.org\/10.1016\/j.jtho.2018.01.012.","journal-title":"Journal of Thoracic Oncology"},{"issue":"8","key":"9949_CR60","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/neuonc\/noz046","volume":"21","author":"R Kotecha","year":"2019","unstructured":"Kotecha, R., Kim, J. M., Miller, J. A., Juloori, A., Chao, S. T., Murphy, E. S., Peereboom, D. M., Mohammadi, A. M., Barnett, G. H., Vogelbaum, M. A., Angelov, L., Suh, J. H., & Ahluwalia, M. S. (2019). The impact of sequencing PD-1\/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis. Neuro-Oncology, 21(8), 1060\u20131068. https:\/\/doi.org\/10.1093\/neuonc\/noz046.","journal-title":"Neuro-Oncology"},{"issue":"2","key":"9949_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/CMR.0000000000000413","volume":"28","author":"C Nardin","year":"2018","unstructured":"Nardin, C., Mateus, C., Texier, M., Lanoy, E., Hibat-Allah, S., Ammari, S., Robert, C., & Dhermain, F. (2018). Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases. Melanoma Research, 28(2), 111\u2013119. https:\/\/doi.org\/10.1097\/CMR.0000000000000413.","journal-title":"Melanoma Research"},{"issue":"3","key":"9949_CR62","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ijrobp.2018.02.175","volume":"101","author":"E Schapira","year":"2018","unstructured":"Schapira, E., Hubbeling, H., Yeap, B. Y., Mehan, W. A., Shaw, A. T., Oh, K., et al. (2018). Improved overall survival and Locoregional disease control with concurrent PD-1 pathway inhibitors and stereotactic radiosurgery for lung cancer patients with brain metastases. International Journal of Radiation Oncology, Biology, Physics, 101(3), 624\u2013629. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.175.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"9949_CR63","doi-asserted-by":"publisher","unstructured":"Shepard, M. J., Xu, Z., Donahue, J., Eluvathingal Muttikkal, T. J., Cordeiro, D., Hansen, L., et al. (2019). Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non\u2013small cell lung cancer to the brain: a matched cohort study. Journal of Neurosurgery, 1\u20138. https:\/\/doi.org\/10.3171\/2019.4.JNS19822.","DOI":"10.3171\/2019.4.JNS19822"},{"issue":"9","key":"9949_CR64","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.3390\/ijms19092653","volume":"19","author":"M Trommer-Nestler","year":"2018","unstructured":"Trommer-Nestler, M., Marnitz, S., Kocher, M., Rue\u00df, D., Schlaak, M., Theurich, S., von Bergwelt-Baildon, M., Morgenthaler, J., Jablonska, K., Celik, E., Ruge, M., & Baues, C. (2018). Robotic stereotactic radiosurgery in melanoma patients with brain metastases under simultaneous anti-PD-1 treatment. International Journal of Molecular Sciences, 19(9), 2653. https:\/\/doi.org\/10.3390\/ijms19092653.","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"9949_CR65","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/nop\/npy042","volume":"6","author":"WT Arscott","year":"2019","unstructured":"Arscott, W. T., Zhu, S., Plastaras, J. P., Maity, A., Alonso-Basanta, M., & Jones, J. (2019). Acute neurologic toxicity of palliative radiotherapy for brain metastases in patients receiving immune checkpoint blockade. Neuro-Oncology Practice, 6(4), 297\u2013304. https:\/\/doi.org\/10.1093\/nop\/npy042.","journal-title":"Neuro-Oncology Practice"},{"issue":"4","key":"9949_CR66","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","volume":"100","author":"L Chen","year":"2018","unstructured":"Chen, L., Douglass, J., Kleinberg, L., Ye, X., Marciscano, A. E., Forde, P. M., Brahmer, J., Lipson, E., Sharfman, W., Hammers, H., Naidoo, J., Bettegowda, C., Lim, M., & Redmond, K. J. (2018). Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma. International Journal of Radiation Oncology, Biology, Physics, 100(4), 916\u2013925. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.11.041.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"9949_CR67","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40425-019-0588-y","volume":"7","author":"G Minniti","year":"2019","unstructured":"Minniti, G., Anzellini, D., Reverberi, C., Cappellini, G. C. A., Marchetti, L., Bianciardi, F., Bozzao, A., Osti, M., Gentile, P. C., & Esposito, V. (2019). Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity. Journal for Immunotherapy of Cancer, 7(1), 102. https:\/\/doi.org\/10.1186\/s40425-019-0588-y.","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"3","key":"9949_CR68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/COC.0000000000000509","volume":"42","author":"B Murphy","year":"2019","unstructured":"Murphy, B., Walker, J., Bassale, S., Monaco, D., Jaboin, J., Ciporen, J., Taylor, M., & Dai Kubicky, C. (2019). Concurrent radiosurgery and immune checkpoint inhibition: improving regional intracranial control for patients with metastatic melanoma. American Journal of Clinical Oncology, 42(3), 253\u2013257. https:\/\/doi.org\/10.1097\/COC.0000000000000509.","journal-title":"American Journal of Clinical Oncology"},{"issue":"19","key":"9949_CR69","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1002\/cncr.30138","volume":"122","author":"JM Qian","year":"2016","unstructured":"Qian, J. M., Yu, J. B., Kluger, H. M., & Chiang, V. L. S. (2016). Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery: immunotherapy and SRS in brain metastases. Cancer, 122(19), 3051\u20133058. https:\/\/doi.org\/10.1002\/cncr.30138.","journal-title":"Cancer"},{"issue":"2","key":"9949_CR70","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-018-2795-7","volume":"138","author":"R Rahman","year":"2018","unstructured":"Rahman, R., Cortes, A., Niemierko, A., Oh, K. S., Flaherty, K. T., Lawrence, D. P., Sullivan, R. J., & Shih, H. A. (2018). The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity. Journal of Neuro-Oncology, 138(2), 299\u2013306. https:\/\/doi.org\/10.1007\/s11060-018-2795-7.","journal-title":"Journal of Neuro-Oncology"},{"key":"9949_CR71","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clineuro.2019.02.010","volume":"179","author":"N Weingarten","year":"2019","unstructured":"Weingarten, N., Kruser, T. J., & Bloch, O. (2019). Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy. Clinical Neurology and Neurosurgery, 179, 14\u201318. https:\/\/doi.org\/10.1016\/j.clineuro.2019.02.010.","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"9949_CR72","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.wneu.2017.01.101","volume":"100","author":"MB Yusuf","year":"2017","unstructured":"Yusuf, M. B., Amsbaugh, M. J., Burton, E., Chesney, J., & Woo, S. (2017). Peri-SRS administration of immune checkpoint therapy for melanoma metastatic to the brain: investigating efficacy and the effects of relative treatment timing on lesion response. World Neurosurgery, 100, 632\u2013640.e4. https:\/\/doi.org\/10.1016\/j.wneu.2017.01.101.","journal-title":"World Neurosurgery"},{"issue":"1","key":"9949_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3171\/2015.6.JNS142763","volume":"125","author":"RJ Colaco","year":"2016","unstructured":"Colaco, R. J., Martin, P., Kluger, H. M., Yu, J. B., & Chiang, V. L. (2016). Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases? Journal of Neurosurgery, 125(1), 17\u201323. https:\/\/doi.org\/10.3171\/2015.6.JNS142763.","journal-title":"Journal of Neurosurgery"},{"issue":"5","key":"9949_CR74","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00280-019-03806-5","volume":"83","author":"E Couty","year":"2019","unstructured":"Couty, E., Vallard, A., Sotton, S., Ouni, S., Garcia, M.-A., Espenel, S., Rancoule, C., Ben Mrad, M., Biron, A. C., Perrot, J. L., Langrand-Escure, J., & Magn\u00e9, N. (2019). Safety assessment of anticancer drugs in association with radiotherapy in metastatic malignant melanoma: a real-life report: radiation\/systemic drug combo in metastatic melanoma. Cancer Chemotherapy and Pharmacology, 83(5), 881\u2013892. https:\/\/doi.org\/10.1007\/s00280-019-03806-5.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"9949_CR75","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1002\/cam4.3021","volume":"9","author":"B Gatterbauer","year":"2020","unstructured":"Gatterbauer, B., Hirschmann, D., Eberherr, N., Untersteiner, H., Cho, A., Shaltout, A., G\u00f6bl, P., Fitschek, F., Dorfer, C., Wolfsberger, S., Kasprian, G., H\u00f6ller, C., & Frischer, J. M. (2020). Toxicity and efficacy of gamma knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy-a retrospective cohort study. Cancer Medicine, 9, 4026\u20134036. https:\/\/doi.org\/10.1002\/cam4.3021.","journal-title":"Cancer Medicine"},{"issue":"1","key":"9949_CR76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13014-020-1485-8","volume":"15","author":"I Hadi","year":"2020","unstructured":"Hadi, I., Roengvoraphoj, O., Bodensohn, R., Hofmaier, J., Niyazi, M., Belka, C., & Nachbichler, S. B. (2020). Stereotactic radiosurgery combined with targeted\/ immunotherapy in patients with melanoma brain metastasis. Radiation Oncology, 15(1), 37. https:\/\/doi.org\/10.1186\/s13014-020-1485-8.","journal-title":"Radiation Oncology"},{"issue":"2","key":"9949_CR77","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-017-2442-8","volume":"133","author":"JM Kim","year":"2017","unstructured":"Kim, J. M., Miller, J. A., Kotecha, R., Xiao, R., Juloori, A., Ward, M. C., Ahluwalia, M. S., Mohammadi, A. M., Peereboom, D. M., Murphy, E. S., Suh, J. H., Barnett, G. H., Vogelbaum, M. A., Angelov, L., Stevens, G. H., & Chao, S. T. (2017). The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies. Journal of Neuro-Oncology, 133(2), 357\u2013368. https:\/\/doi.org\/10.1007\/s11060-017-2442-8.","journal-title":"Journal of Neuro-Oncology"},{"issue":"3","key":"9949_CR78","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.clgc.2019.02.007","volume":"17","author":"G Klausner","year":"2019","unstructured":"Klausner, G., Troussier, I., Biau, J., Jacob, J., Schernberg, A., Canova, C.-H., Simon, J. M., Borius, P. Y., Malouf, G., Spano, J. P., Roupret, M., Cornu, P., Mazeron, J. J., Val\u00e9ry, C., Feuvret, L., & Maingon, P. (2019). Stereotactic radiation therapy for renal cell carcinoma brain metastases in the tyrosine kinase inhibitors era: outcomes of 120 patients. Clinical Genitourinary Cancer, 17(3), 191\u2013200. https:\/\/doi.org\/10.1016\/j.clgc.2019.02.007.","journal-title":"Clinical Genitourinary Cancer"},{"issue":"1","key":"9949_CR79","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3171\/2017.1.JNS162797","volume":"129","author":"R Kotecha","year":"2018","unstructured":"Kotecha, R., Miller, J. A., Venur, V. A., Mohammadi, A. M., Chao, S. T., Suh, J. H., Barnett, G. H., Murphy, E. S., Funchain, P., Yu, J. S., Vogelbaum, M. A., Angelov, L., & Ahluwalia, M. S. (2018). Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and\/or immune-based therapies on treatment outcome. Journal of Neurosurgery, 129(1), 50\u201359. https:\/\/doi.org\/10.3171\/2017.1.JNS162797.","journal-title":"Journal of Neurosurgery"},{"issue":"12","key":"9949_CR80","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/cncr.30616","volume":"123","author":"JA Miller","year":"2017","unstructured":"Miller, J. A., Kotecha, R., Ahluwalia, M. S., Mohammadi, A. M., Chao, S. T., Barnett, G. H., Murphy, E. S., Vogelbaum, M. A., Angelov, L., Peereboom, D. M., & Suh, J. H. (2017). Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies: breast cancer brain metastasis. Cancer, 123(12), 2283\u20132293. https:\/\/doi.org\/10.1002\/cncr.30616.","journal-title":"Cancer"},{"issue":"2","key":"9949_CR81","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijrobp.2016.01.054","volume":"95","author":"CJ Shen","year":"2016","unstructured":"Shen, C. J., Kummerlowe, M. N., Redmond, K. J., Rigamonti, D., Lim, M. K., & Kleinberg, L. R. (2016). Stereotactic radiosurgery: treatment of brain metastasis without interruption of systemic therapy. International Journal of Radiation Oncology, Biology, Physics, 95(2), 735\u2013742. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.01.054.","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"9949_CR82","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/CMR.0000000000000542","volume":"29","author":"S Stera","year":"2019","unstructured":"Stera, S., Balermpas, P., Blanck, O., Wolff, R., Wurster, S., Baumann, R., Sz\u00fccs, M., Loutfi-Krauss, B., Wilhelm, M. L., Seifert, V., Rades, D., R\u00f6del, C., Dunst, J., Hildebrandt, G., Arnold, A., Meissner, M., & K\u00e4hler, K. C. (2019). Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma. Melanoma Research, 29(2), 187\u2013195. https:\/\/doi.org\/10.1097\/CMR.0000000000000542.","journal-title":"Melanoma Research"},{"key":"9949_CR83","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ctrv.2016.11.013","volume":"53","author":"SGC Kroeze","year":"2017","unstructured":"Kroeze, S. G. C., Fritz, C., Hoyer, M., Lo, S. S., Ricardi, U., Sahgal, A., Stahel, R., Stupp, R., & Guckenberger, M. (2017). Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review. Cancer Treatment Reviews, 53, 25\u201337. https:\/\/doi.org\/10.1016\/j.ctrv.2016.11.013.","journal-title":"Cancer Treatment Reviews"},{"issue":"2","key":"9949_CR84","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","volume":"123","author":"PK Sneed","year":"2015","unstructured":"Sneed, P. K., Mendez, J., Vemer-van den Hoek, J. G. M., Seymour, Z. A., Ma, L., Molinaro, A. M., Fogh, S. E., Nakamura, J. L., & McDermott, M. W. (2015). Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. Journal of Neurosurgery, 123(2), 373\u2013386. https:\/\/doi.org\/10.3171\/2014.10.JNS141610.","journal-title":"Journal of Neurosurgery"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09949-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-020-09949-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09949-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T16:47:46Z","timestamp":1613839666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-020-09949-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9949"],"URL":"https:\/\/doi.org\/10.1007\/s10555-020-09949-9","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"13 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}